Oral Vaccine Market Report

Global and Regional Oral Vaccine Market Details Research Report 2021-2026

  • POSTDATE：Jun 24, 2021
  • PAGES：236
  • REPORT CODE：GMM711757
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Oral Vaccine Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Oral Vaccine market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Oral Vaccine market.

    By Player:

    • Merck

    • PaxVax

    • GSK

    • Serum Institute

    • Bibcol

    • Tiantan Biological

    • Valneva

    • Shanghai United Cell

    • Bio-Med

    • EuBiologics

    • Lanzhou Institute

    • Halfkin Bio-Pharmaceuticals

    • Panacea Biotec Ltd

    • Sanofi

    • Vabiotech

    By Type:

    • Rotavirus Vaccine

    • Cholera Vaccine

    • Oral Polio Vaccine

    • Others

    By End-User:

    • Public

    • Private

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Oral Vaccine Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Oral Vaccine Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Oral Vaccine Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Oral Vaccine Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Oral Vaccine Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Oral Vaccine Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Merck

      • 3.1.1 Merck - Company Business Overview

      • 3.1.2 Merck - Company Financial Performance

      • 3.1.3 Merck - Company Financial Performance of Oral Vaccine

      • 3.1.4 Oral Vaccine Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 PaxVax

      • 3.2.1 PaxVax - Company Business Overview

      • 3.2.2 PaxVax - Company Financial Performance

      • 3.2.3 PaxVax - Company Financial Performance of Oral Vaccine

      • 3.2.4 Oral Vaccine Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 GSK

      • 3.3.1 GSK - Company Business Overview

      • 3.3.2 GSK - Company Financial Performance

      • 3.3.3 GSK - Company Financial Performance of Oral Vaccine

      • 3.3.4 Oral Vaccine Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Serum Institute

      • 3.4.1 Serum Institute - Company Business Overview

      • 3.4.2 Serum Institute - Company Financial Performance

      • 3.4.3 Serum Institute - Company Financial Performance of Oral Vaccine

      • 3.4.4 Oral Vaccine Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Bibcol

      • 3.5.1 Bibcol - Company Business Overview

      • 3.5.2 Bibcol - Company Financial Performance

      • 3.5.3 Bibcol - Company Financial Performance of Oral Vaccine

      • 3.5.4 Oral Vaccine Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Tiantan Biological

      • 3.6.1 Tiantan Biological - Company Business Overview

      • 3.6.2 Tiantan Biological - Company Financial Performance

      • 3.6.3 Tiantan Biological - Company Financial Performance of Oral Vaccine

      • 3.6.4 Oral Vaccine Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Valneva

      • 3.7.1 Valneva - Company Business Overview

      • 3.7.2 Valneva - Company Financial Performance

      • 3.7.3 Valneva - Company Financial Performance of Oral Vaccine

      • 3.7.4 Oral Vaccine Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Shanghai United Cell

      • 3.8.1 Shanghai United Cell - Company Business Overview

      • 3.8.2 Shanghai United Cell - Company Financial Performance

      • 3.8.3 Shanghai United Cell - Company Financial Performance of Oral Vaccine

      • 3.8.4 Oral Vaccine Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Bio-Med

      • 3.9.1 Bio-Med - Company Business Overview

      • 3.9.2 Bio-Med - Company Financial Performance

      • 3.9.3 Bio-Med - Company Financial Performance of Oral Vaccine

      • 3.9.4 Oral Vaccine Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 EuBiologics

      • 3.10.1 EuBiologics - Company Business Overview

      • 3.10.2 EuBiologics - Company Financial Performance

      • 3.10.3 EuBiologics - Company Financial Performance of Oral Vaccine

      • 3.10.4 Oral Vaccine Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Lanzhou Institute

      • 3.11.1 Lanzhou Institute - Company Business Overview

      • 3.11.2 Lanzhou Institute - Company Financial Performance

      • 3.11.3 Lanzhou Institute - Company Financial Performance of Oral Vaccine

      • 3.11.4 Oral Vaccine Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Halfkin Bio-Pharmaceuticals

      • 3.12.1 Halfkin Bio-Pharmaceuticals - Company Business Overview

      • 3.12.2 Halfkin Bio-Pharmaceuticals - Company Financial Performance

      • 3.12.3 Halfkin Bio-Pharmaceuticals - Company Financial Performance of Oral Vaccine

      • 3.12.4 Oral Vaccine Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Panacea Biotec Ltd

      • 3.13.1 Panacea Biotec Ltd - Company Business Overview

      • 3.13.2 Panacea Biotec Ltd - Company Financial Performance

      • 3.13.3 Panacea Biotec Ltd - Company Financial Performance of Oral Vaccine

      • 3.13.4 Oral Vaccine Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 Sanofi

      • 3.14.1 Sanofi - Company Business Overview

      • 3.14.2 Sanofi - Company Financial Performance

      • 3.14.3 Sanofi - Company Financial Performance of Oral Vaccine

      • 3.14.4 Oral Vaccine Product Benchmarking

      • 3.14.5 Strategic Initiatives

    • 3.15 Vabiotech

      • 3.15.1 Vabiotech - Company Business Overview

      • 3.15.2 Vabiotech - Company Financial Performance

      • 3.15.3 Vabiotech - Company Financial Performance of Oral Vaccine

      • 3.15.4 Oral Vaccine Product Benchmarking

      • 3.15.5 Strategic Initiatives

    4 Global Oral Vaccine Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Oral Vaccine Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Rotavirus Vaccine 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Cholera Vaccine 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Oral Polio Vaccine 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Others 2016-2021

    • 4.3 Global Oral Vaccine Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Rotavirus Vaccine 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Cholera Vaccine 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Oral Polio Vaccine 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Others 2016-2021

    • 4.4 Global Oral Vaccine Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Oral Vaccine Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Oral Vaccine Market Price By Type from 2016 to 2026

    5 Global Oral Vaccine Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Oral Vaccine

    • 5.2 Global Oral Vaccine Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Public 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Private 2016-2021

    • 5.3 Global Oral Vaccine Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Public 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Private 2016-2021

    • 5.4 Global Oral Vaccine Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Oral Vaccine Market Sales and Market Share by Application (Forecast)

    6 Global Oral Vaccine Market Segment Analysis (Geography Level)

    • 6.1 Global Oral Vaccine Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Oral Vaccine Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Oral Vaccine Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Oral Vaccine Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Oral Vaccine Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Oral Vaccine Market from 2016 to 2020

    7. North America Oral Vaccine Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Oral Vaccine Market Segment by Countries

      • 7.1.1 North America Oral Vaccine Market Revenue Segment by Countries

      • 7.1.2 North America Oral Vaccine Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Oral Vaccine Market Segment (Product Type Level)

    • 7.3 North America Oral Vaccine Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Oral Vaccine Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Oral Vaccine Market Segment by Countries

      • 8.1.1 Europe Oral Vaccine Market Revenue Segment by Countries

      • 8.1.2 Europe Oral Vaccine Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Oral Vaccine Market Segment (Product Type Level)

    • 8.3 Europe Oral Vaccine Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Oral Vaccine Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Oral Vaccine Market Segment by Countries

      • 9.1.1 Asia Oral Vaccine Market Revenue Segment by Countries

      • 9.1.2 Asia Oral Vaccine Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Oral Vaccine Market Segment (Product Type Level)

    • 9.3 Asia Oral Vaccine Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Oral Vaccine Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Oral Vaccine Market Segment by Countries

      • 10.1.1 South America Oral Vaccine Market Revenue Segment by Countries

      • 10.1.2 South America Oral Vaccine Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Oral Vaccine Market Segment (Product Type Level)

    • 10.3 South America Oral Vaccine Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Oral Vaccine Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Oral Vaccine Market Segment by Countries

      • 11.1.1 Middle East Oral Vaccine Market Revenue Segment by Countries

      • 11.1.2 Middle East Oral Vaccine Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Oral Vaccine Market Segment (Product Type Level)

    • 11.3 Middle East Oral Vaccine Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Oral Vaccine Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Oral Vaccine Market Segment by Countries

      • 12.1.1 Africa Oral Vaccine Market Revenue Segment by Countries

      • 12.1.2 Africa Oral Vaccine Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Oral Vaccine Market Segment (Product Type Level)

    • 12.3 Africa Oral Vaccine Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Oral Vaccine Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Oral Vaccine Market Segment by Countries

      • 13.1.1 Oceania Oral Vaccine Market Revenue Segment by Countries

      • 13.1.2 Oceania Oral Vaccine Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Oral Vaccine Market Segment (Product Type Level)

    • 13.3 Oceania Oral Vaccine Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Oral Vaccine Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Oral Vaccine

      • 14.2.2 Manufacturing Process Analysis of Oral Vaccine

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Oral Vaccine Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Oral Vaccine Industry Market Status, Pre-COVID-19

      • 15.5.3 Oral Vaccine Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Oral Vaccine Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Oral Vaccine Product Picture

    • Table Oral Vaccine Product Definition

    • Table Study Scope by Types

    • Figure Global Oral Vaccine Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Oral Vaccine Market Value by Application (2016 - 2026)

    • Figure Global Oral Vaccine Market Size and Growth Rate from 2016 to 2026

    • Table Global Oral Vaccine Production Capacity by Manufacturers (2016-2021)

    • Table Global Oral Vaccine Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Oral Vaccine Revenue by Manufacturers (2016-2021)

    • Table Global Oral Vaccine Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Oral Vaccine Plant Distribution and Sales Country

    • Table Merck - Company Business Overview

    • Figure Merck Total Revenue from 2018 to 2020

    • Table Merck Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Merck Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Merck

    • Table Oral Vaccine Product Benchmarking

    • Table PaxVax - Company Business Overview

    • Figure PaxVax Total Revenue from 2018 to 2020

    • Table PaxVax Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure PaxVax Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of PaxVax

    • Table Oral Vaccine Product Benchmarking

    • Table GSK - Company Business Overview

    • Figure GSK Total Revenue from 2018 to 2020

    • Table GSK Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GSK Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of GSK

    • Table Oral Vaccine Product Benchmarking

    • Table Serum Institute - Company Business Overview

    • Figure Serum Institute Total Revenue from 2018 to 2020

    • Table Serum Institute Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Serum Institute Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Serum Institute

    • Table Oral Vaccine Product Benchmarking

    • Table Bibcol - Company Business Overview

    • Figure Bibcol Total Revenue from 2018 to 2020

    • Table Bibcol Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bibcol Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Bibcol

    • Table Oral Vaccine Product Benchmarking

    • Table Tiantan Biological - Company Business Overview

    • Figure Tiantan Biological Total Revenue from 2018 to 2020

    • Table Tiantan Biological Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Tiantan Biological Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Tiantan Biological

    • Table Oral Vaccine Product Benchmarking

    • Table Valneva - Company Business Overview

    • Figure Valneva Total Revenue from 2018 to 2020

    • Table Valneva Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Valneva Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Valneva

    • Table Oral Vaccine Product Benchmarking

    • Table Shanghai United Cell - Company Business Overview

    • Figure Shanghai United Cell Total Revenue from 2018 to 2020

    • Table Shanghai United Cell Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Shanghai United Cell Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Shanghai United Cell

    • Table Oral Vaccine Product Benchmarking

    • Table Bio-Med - Company Business Overview

    • Figure Bio-Med Total Revenue from 2018 to 2020

    • Table Bio-Med Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bio-Med Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Bio-Med

    • Table Oral Vaccine Product Benchmarking

    • Table EuBiologics - Company Business Overview

    • Figure EuBiologics Total Revenue from 2018 to 2020

    • Table EuBiologics Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure EuBiologics Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of EuBiologics

    • Table Oral Vaccine Product Benchmarking

    • Table Lanzhou Institute - Company Business Overview

    • Figure Lanzhou Institute Total Revenue from 2018 to 2020

    • Table Lanzhou Institute Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Lanzhou Institute Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Lanzhou Institute

    • Table Oral Vaccine Product Benchmarking

    • Table Halfkin Bio-Pharmaceuticals - Company Business Overview

    • Figure Halfkin Bio-Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Halfkin Bio-Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Halfkin Bio-Pharmaceuticals Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Halfkin Bio-Pharmaceuticals

    • Table Oral Vaccine Product Benchmarking

    • Table Panacea Biotec Ltd - Company Business Overview

    • Figure Panacea Biotec Ltd Total Revenue from 2018 to 2020

    • Table Panacea Biotec Ltd Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Panacea Biotec Ltd Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Panacea Biotec Ltd

    • Table Oral Vaccine Product Benchmarking

    • Table Sanofi - Company Business Overview

    • Figure Sanofi Total Revenue from 2018 to 2020

    • Table Sanofi Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sanofi Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Oral Vaccine Product Benchmarking

    • Table Vabiotech - Company Business Overview

    • Figure Vabiotech Total Revenue from 2018 to 2020

    • Table Vabiotech Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Vabiotech Sales and Growth Rate Analysis of Oral Vaccine

    • Figure Revenue and Market Share Analysis of Vabiotech

    • Table Oral Vaccine Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Oral Vaccine Market Revenue by Types (Historical)

    • Table Global Oral Vaccine Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Rotavirus Vaccine 2016-2021

    • Figure Global Revenue and Growth Rate of Cholera Vaccine 2016-2021

    • Figure Global Revenue and Growth Rate of Oral Polio Vaccine 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global Oral Vaccine Market Sales by Types (Historical)

    • Table Global Oral Vaccine Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Rotavirus Vaccine 2016-2021

    • Figure Global Sales and Growth Rate of Cholera Vaccine 2016-2021

    • Figure Global Sales and Growth Rate of Oral Polio Vaccine 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global Oral Vaccine Market Revenue by Types (Forecast)

    • Table Global Oral Vaccine Market Revenue Market Share by Types (Forecast)

    • Table Global Oral Vaccine Market Sales by Types (Forecast)

    • Table Global Oral Vaccine Market Sales Market Share by Types (Forecast)

    • Figure Global Oral Vaccine Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Oral Vaccine

    • Table Global Oral Vaccine Market Revenue by Application (Historical)

    • Table Global Oral Vaccine Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Public 2016-2021

    • Figure Global Revenue and Growth Rate of Private 2016-2021

    • Table Global Oral Vaccine Market Sales by Application (Historical)

    • Table Global Oral Vaccine Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Public 2016-2021

    • Figure Global Sales and Growth Rate of Private 2016-2021

    • Table Global Oral Vaccine Market Revenue by Application (Forecast)

    • Table Global Oral Vaccine Market Revenue Market Share by Application (Forecast)

    • Table Global Oral Vaccine Market Sales by Application (Forecast)

    • Table Global Oral Vaccine Market Sales Market Share by Application (Forecast)

    • Table Global Oral Vaccine Market Revenue by Geography (Historical)

    • Table Global Oral Vaccine Market Revenue Market Share by Geography (Historical)

    • Figure Global Oral Vaccine Revenue Market Share by Geography in 2020

    • Table Global Oral Vaccine Market Sales by Geography (Historical)

    • Table Global Oral Vaccine Market Sales Market Share by Geography (Historical)

    • Figure Global Oral Vaccine Sales Market Share by Geography in 2020

    • Table Global Oral Vaccine Market Revenue by Geography (Forecast)

    • Table Global Oral Vaccine Market Revenue Market Share by Geography (Forecast)

    • Table Global Oral Vaccine Market Sales by Geography (Forecast)

    • Table Global Oral Vaccine Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Oral Vaccine Revenue by Countries from 2016 to 2026

    • Table North America Oral Vaccine Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Oral Vaccine Revenue Market Share by Major Countries in 2020

    • Table North America Oral Vaccine Sales by Countries from 2016 to 2026

    • Table North America Oral Vaccine Sales Market Share by Countries from 2016 to 2026

    • Figure North America Oral Vaccine Sales Market Share by Major Countries in 2020

    • Figure USA Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure USA Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Table North America Oral Vaccine Sales by Types from 2016 to 2026

    • Table North America Oral Vaccine Sales Market Share by Types from 2016 to 2026

    • Table North America Oral Vaccine Value by Types from 2016 to 2026

    • Table North America Oral Vaccine Value Market Share by Types from 2016 to 2026

    • Table North America Oral Vaccine Sales by Application from 2016 to 2026

    • Table North America Oral Vaccine Sales Market Share by Application from 2016 to 2026

    • Table North America Oral Vaccine Value by Application from 2016 to 2026

    • Table North America Oral Vaccine Value Market Share by Application from 2016 to 2026

    • Table Europe Oral Vaccine Revenue by Countries from 2016 to 2026

    • Table Europe Oral Vaccine Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Oral Vaccine Revenue Market Share by Major Countries in 2020

    • Table Europe Oral Vaccine Sales by Countries from 2016 to 2026

    • Table Europe Oral Vaccine Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Oral Vaccine Sales Market Share by Major Countries in 2020

    • Figure Germany Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure France Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure France Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Oral Vaccine Sales by Types from 2016 to 2026

    • Table Europe Oral Vaccine Sales Market Share by Types from 2016 to 2026

    • Table Europe Oral Vaccine Value by Types from 2016 to 2026

    • Table Europe Oral Vaccine Value Market Share by Types from 2016 to 2026

    • Table Europe Oral Vaccine Sales by Application from 2016 to 2026

    • Table Europe Oral Vaccine Sales Market Share by Application from 2016 to 2026

    • Table Europe Oral Vaccine Value by Application from 2016 to 2026

    • Table Europe Oral Vaccine Value Market Share by Application from 2016 to 2026

    • Table Asia Oral Vaccine Revenue by Countries from 2016 to 2026

    • Table Asia Oral Vaccine Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Oral Vaccine Revenue Market Share by Major Countries in 2020

    • Table Asia Oral Vaccine Sales by Countries from 2016 to 2026

    • Table Asia Oral Vaccine Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Oral Vaccine Sales Market Share by Major Countries in 2020

    • Figure China Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure China Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure India Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure India Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Oral Vaccine Sales by Types from 2016 to 2026

    • Table Asia Oral Vaccine Sales Market Share by Types from 2016 to 2026

    • Table Asia Oral Vaccine Value by Types from 2016 to 2026

    • Table Asia Oral Vaccine Value Market Share by Types from 2016 to 2026

    • Table Asia Oral Vaccine Sales by Application from 2016 to 2026

    • Table Asia Oral Vaccine Sales Market Share by Application from 2016 to 2026

    • Table Asia Oral Vaccine Value by Application from 2016 to 2026

    • Table Asia Oral Vaccine Value Market Share by Application from 2016 to 2026

    • Table South America Oral Vaccine Revenue by Countries from 2016 to 2026

    • Table South America Oral Vaccine Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Oral Vaccine Revenue Market Share by Major Countries in 2020

    • Table South America Oral Vaccine Sales by Countries from 2016 to 2026

    • Table South America Oral Vaccine Sales Market Share by Countries from 2016 to 2026

    • Figure South America Oral Vaccine Sales Market Share by Major Countries in 2020

    • Figure Brazil Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Table South America Oral Vaccine Sales by Types from 2016 to 2026

    • Table South America Oral Vaccine Sales Market Share by Types from 2016 to 2026

    • Table South America Oral Vaccine Value by Types from 2016 to 2026

    • Table South America Oral Vaccine Value Market Share by Types from 2016 to 2026

    • Table South America Oral Vaccine Sales by Application from 2016 to 2026

    • Table South America Oral Vaccine Sales Market Share by Application from 2016 to 2026

    • Table South America Oral Vaccine Value by Application from 2016 to 2026

    • Table South America Oral Vaccine Value Market Share by Application from 2016 to 2026

    • Table Middle East Oral Vaccine Revenue by Countries from 2016 to 2026

    • Table Middle East Oral Vaccine Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Oral Vaccine Revenue Market Share by Major Countries in 2020

    • Table Middle East Oral Vaccine Sales by Countries from 2016 to 2026

    • Table Middle East Oral Vaccine Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Oral Vaccine Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Oral Vaccine Sales by Types from 2016 to 2026

    • Table Middle East Oral Vaccine Sales Market Share by Types from 2016 to 2026

    • Table Middle East Oral Vaccine Value by Types from 2016 to 2026

    • Table Middle East Oral Vaccine Value Market Share by Types from 2016 to 2026

    • Table Middle East Oral Vaccine Sales by Application from 2016 to 2026

    • Table Middle East Oral Vaccine Sales Market Share by Application from 2016 to 2026

    • Table Middle East Oral Vaccine Value by Application from 2016 to 2026

    • Table Middle East Oral Vaccine Value Market Share by Application from 2016 to 2026

    • Table Africa Oral Vaccine Revenue by Countries from 2016 to 2026

    • Table Africa Oral Vaccine Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Oral Vaccine Revenue Market Share by Major Countries in 2020

    • Table Africa Oral Vaccine Sales by Countries from 2016 to 2026

    • Table Africa Oral Vaccine Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Oral Vaccine Sales Market Share by Major Countries in 2020

    • Figure Nigeria Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Oral Vaccine Sales by Types from 2016 to 2026

    • Table Africa Oral Vaccine Sales Market Share by Types from 2016 to 2026

    • Table Africa Oral Vaccine Value by Types from 2016 to 2026

    • Table Africa Oral Vaccine Value Market Share by Types from 2016 to 2026

    • Table Africa Oral Vaccine Sales by Application from 2016 to 2026

    • Table Africa Oral Vaccine Sales Market Share by Application from 2016 to 2026

    • Table Africa Oral Vaccine Value by Application from 2016 to 2026

    • Table Africa Oral Vaccine Value Market Share by Application from 2016 to 2026

    • Table Oceania Oral Vaccine Revenue by Countries from 2016 to 2026

    • Table Oceania Oral Vaccine Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Oral Vaccine Revenue Market Share by Major Countries in 2020

    • Table Oceania Oral Vaccine Sales by Countries from 2016 to 2026

    • Table Oceania Oral Vaccine Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Oral Vaccine Sales Market Share by Major Countries in 2020

    • Figure Australia Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Oral Vaccine Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Oral Vaccine Sales by Types from 2016 to 2026

    • Table Oceania Oral Vaccine Sales Market Share by Types from 2016 to 2026

    • Table Oceania Oral Vaccine Value by Types from 2016 to 2026

    • Table Oceania Oral Vaccine Value Market Share by Types from 2016 to 2026

    • Table Oceania Oral Vaccine Sales by Application from 2016 to 2026

    • Table Oceania Oral Vaccine Sales Market Share by Application from 2016 to 2026

    • Table Oceania Oral Vaccine Value by Application from 2016 to 2026

    • Table Oceania Oral Vaccine Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Oral Vaccine

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Oral Vaccine with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US